Astera Labs (NASDAQ:ALAB) Stock Price Down 9.2% – Here’s What Happened

Astera Labs, Inc. (NASDAQ:ALAB) dropped 9.2% on Thursday. The stock traded as low as $342.54 and last traded at $347.05. Approximately 6,413,945 shares changed hands during mid-day trading, an increase of 23% from the average daily volume of 5,196,890 shares. The stock had previously closed at $382.25.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs introduced Aries 7, described as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The lineup includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers, positioning the company to benefit from expanding AI infrastructure and higher-speed data-center connectivity. Astera Labs Announces Aries 7
• Positive Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business reinforced investor optimism about the broader AI-connectivity market and helped highlight Astera’s growth opportunity. However, the companies discussed in the coverage remain dependent on major customers. Marvell AI Connectivity Market Forecast
• Neutral Sentiment: Analysts and market coverage are comparing Astera’s role in connecting AI racks with Micron’s memory and system exposure. Astera offers substantial growth potential, but competition from Marvell and Credo is intensifying. Micron Versus Astera Labs
• Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” adding pressure to the shares and signaling that the current valuation may already reflect substantial AI-related growth. Northland Securities Downgrade
• Negative Sentiment: Jim Cramer praised Astera’s business but criticized its price, reinforcing concerns that the stock’s valuation leaves limited room for execution mistakes or slower growth. Jim Cramer Discusses Astera Labs Valuation

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of research reports. UBS Group restated a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. TD Cowen decreased their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday, August 5th. Roth Capital reaffirmed a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Susquehanna upped their target price on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, Morgan Stanley boosted their price target on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Eleven research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Price Performance

The business’s 50 day simple moving average is $317.44 and its 200 day simple moving average is $290.39. The company has a market capitalization of $59.37 billion, a price-to-earnings ratio of 169.41 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts expect that Astera Labs, Inc. will post 2.70 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, Director Stefan Dyckerhoff sold 8,994 shares of the stock in a transaction on Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the completion of the sale, the director directly owned 2,648 shares of the company’s stock, valued at $995,806.88. This trade represents a 77.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 408,558 shares of company stock valued at $127,306,034. Corporate insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Reflection Asset Management acquired a new position in shares of Astera Labs during the 4th quarter worth $25,000. Keating Financial Advisory Services Inc. purchased a new position in Astera Labs in the second quarter valued at about $25,000. GK Wealth Management LLC acquired a new stake in shares of Astera Labs during the 3rd quarter valued at approximately $29,000. Archer Investment Corp purchased a new stake in shares of Astera Labs during the 2nd quarter worth approximately $30,000. Finally, Whipplewood Advisors LLC increased its stake in Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.